Sort   by:  
 Page size 
UnknownStewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial.
Not available
S-EPMC11185977 | biostudies-literature
UnknownStewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial.
Not available
S-EPMC11185978 | biostudies-literature
UnknownRandomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).
Not available
S-EPMC12875868 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownTauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol.
Not available
S-EPMC9552801 | biostudies-literature
UnknownA randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.
Not available
S-EPMC10696667 | biostudies-literature
UnknownAre Environmental Factors for Atopic Eczema in ISAAC Phase Three due to Reverse Causation?
Not available
S-EPMC6478380 | biostudies-literature
UnknownGestaltMatcher Database - A global reference for facial phenotypic variability in rare human diseases.
Not available
S-EPMC10371103 | biostudies-literature
UnknownExamination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children.
Not available
S-EPMC9857632 | biostudies-literature
UnknownLong-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743 | biostudies-literature
Sort   by:  
 Page size